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Abstract  
The production of short peptides as single molecules in recombinant systems is often limited by 
the low stability of the foreign peptide. In the plant expression system this problem has been 
solved by translational fusions to recombinant proteins that are highly stable or are able to form 
complex structures. Previously, we demonstrated that the highly immunogenic 21 amino acid 
peptide 2L21, which is derived from the canine parvovirus (CPV) VP2 protein, did not 
accumulate in transgenic tobacco chloroplasts. In this report, we translationally fused the 2L21 
peptide to the 42 amino acid tetramerisation domain (TD) from the human transcription factor 
p53. The chimaeric 2L21-TD protein was expressed in tobacco chloroplasts. Leaves 
accumulated high levels of the recombinant protein (up to 0.4 mg/g fresh weight of leaf material, 
equivalent to ∼6% of total soluble protein; 2% considering only the 2L21 peptide). The 2L21-TD 
protein was able to form tetramers in the stroma of the chloroplast. Mice immunised 
intraperitoneally with partially purified leaf extracts containing the 2L21-TD protein developed 
specific antibodies with titres similar to those elicited by a previously reported fusion between 
2L21 and the B subunit of the cholera toxin. Mouse sera were able to detect both the 2L21 
synthetic peptide and the CPV VP2 protein, showing that the antigenicity of the 2L21 epitope 
was preserved in the chimaeric protein. These results demonstrate that the p53 TD can be used 
as a carrier molecule for the accumulation of short peptides (such as 2L21) in the chloroplast 
without altering the immunogenic properties of the peptide. 
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Introduction 
One of the problems related to foreign protein production in nuclear transgenic plants is often 
the low accumulation of the protein of interest. Yields depend on both the synthesis and stability 
of xenoproteins. The usual strategy to improve the yield of recombinant proteins is to maximise 
the efficiency of gene expression and protein stability by targeting the protein to specific 
subcellular compartments and selecting the appropriate tissue type (Fischer et al. 2004; 
Streatfield 2007; Twyman et al. 2003). 
Plastid transformation is an alternative method to increase foreign protein yield. Recently, a 
phage lytic protein for antibiotic use was expressed in tobacco chloroplasts at very high levels 
(more than 70% of the total soluble protein, TSP) (Oey et al. 2009a). This shows the enormous 
capacity of the chloroplast to produce and accumulate recombinant proteins.  
The expression of peptides as independent products in transgenic plants seems to be difficult, 
probably due to low stability of the foreign peptide (Düring 2001; Florack et al.1995; Molina et al. 
2004). This problem has been circumvented by translational fusions to recombinant proteins. 
Fusion of a peptide antigen to a carrier protein that has been shown to accumulate in plants can 
stabilise the target peptide. Translational fusions to GUS (Dus Santos et al. 2002; Gil et al. 
2001) or to proteins that naturally produce multimeric structures have been proven to be 
effective for the expression of peptide antigens. For example, the fusion of a tuberculosis 
antigen to the B subunit of the Escherichia coli heat-labile enterotoxin (LTB), which self-
assembles as a pentamer (Rigano et al. 2004), and the fusion of amino acids 21-47 of the 
hepatocyte receptor-binding presurface 1 region with the hepatitis B virus surface antigen, 
which is able to form virus-like particles (Qian et al. 2008), follow this strategy.  
As an alternative to large protein carriers, the 42 amino acid fragment containing the 
tetramerisation domain (TD) of the human transcription factor p53 (Sakamoto et al. 1994) was 
fused to a highly immunogenic peptide antigen (2L21) derived from the canine parvovirus (CPV)  
VP2 protein (Gil et al. 2007). Nuclear transgenic Arabidopsis plants produced stable peptide 
tetramers that accumulated to more than 1% of TSP and elicited specific humoral responses in 
mice. In a previous work, we generated transplastomic tobacco plants with a nucleotide 
sequence encoding the 21 amino acid 2L21 peptide antigen (Molina et al. 2004). Despite the 
presence of the specific mRNA, the peptide did not accumulate in tobacco chloroplasts. Here, 
we produced transplastomic tobacco plants carrying a translational fusion between the TD and 
the 2L21 peptide to analyse the validity of this fusion strategy in the chloroplast. Our results 
show that the p53 TD mediated tetramerisation of the 2L21 peptide, and that the recombinant 
protein accumulated to up to 6% of TSP in young leaves. Chimaeric 2L21-TD tetramers elicited 
the production of specific antibodies able to recognize the VP2 protein of CPV after mouse 
immunisation. 
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Results and discussion 
 
The DNA sequence corresponding to the 2L21 epitope (22 amino acids, including the initial 
methionine), fused in frame to the sequence of the p53 TD (42 amino acids), was inserted in the 
pAF chloroplast expression vector (Fernandez-San Millan et al. 2008), giving the pAF-2L21-TD 
vector (Figure 1a). The recombinant protein included a carboxy terminal 6xHis-tag. 
Chloroplast transformation of tobacco (Nicotiana tabacum var. Petite Havana) was performed 
by particle bombardment of in vitro-grown leaves with gold microparticles coated with plasmid 
pAF-2L21-TD as described previously (Daniell 1997). Stable integration of the foreign genes 
into the plastid genome of regenerated plants was confirmed by PCR by using the primer pair 
3P/3M (Figure 1a). The expected 1.65 kb PCR product was obtained in all the transplastomic 
plants analysed but was absent in the wild-type plant (Figure 1b). Confirmed PCR transformants 
were subjected to Southern blot analysis. The 0.81 kb probe, homologous to the flanking 
regions trnI and trnA (Figure 1a), was used to check homoplasmy (all the plastid genomes in a 
single cell and all the cells of the plant were transformed). Transplastomic plants produced two 
fragments (5.21 and 1.13 kb), whereas the wild-type plant produced a single fragment of 4.47 
kb (Figure 1a). Plants #2, #3 and #6 were homoplasmic, and the rest were heteroplasmic 
(presence of both transformed and wild-type plastid genomes) (Figure 1c).  
The detection of the chimaeric polypeptide in transplastomic plants was performed with the 
monoclonal antibody (mAb) 3C9 (specific for the 2L21 epitope; Ingenasa, Spain). Total soluble 
protein was obtained by grinding leaves in phosphate-buffered saline (PBS), pH 7.4 (1:1 w/v). 
After centrifugation, the supernatant was the soluble fraction and the pellet was resuspended in 
3 volumes (w/v) of Laemmli buffer (Laemmli 1970). After boiling and centrifugation, the new 
supernatant was considered the insoluble fraction. As can be observed in Figure 2a, the soluble 
and insoluble fractions of the three homoplasmic plants showed a clear signal of the expected 
size (8 kDa) for the monomeric 2L21-TD. No signal was detected in protein extracts from plants 
transformed with the nucleotide sequence encoding the 2L21 peptide as an independent 
sequence (Figure 2a). Despite the denaturing conditions, bands corresponding to oligomeric 
structures were also detected. The CPV VP2 protein was used as a positive control. There was 
no cross-reaction between mAb 3C9 and wild-type tobacco proteins. Similar expression levels 
of 2L21-TD were observed in the different plants. Most of the protein was present in the soluble 
fraction. Line #2 was selected and self-pollinated to obtain the T1 generation. Leaf material from 
these plants was used for further experiments.  
The formation of oligomeric structures was tested with unboiled soluble protein extracts 
(obtained as described above and loaded in the gel with buffer lacking SDS and b-
mercaptoethanol) that were resolved by 12% PAGE (including tricine). Western blot analysis 
showed the presence of a band with an electrophoretic mobility of ∼32 kDa, as was expected for 
the 2L21-TD tetramer (Figure 2b). A boiled sample with loading buffer including SDS and b-
mercaptoethanol showed a predominant band of 8 kDa, corresponding to the monomer, and 
faint bands of the trimer, tetramer and higher oligomeric structures. This result demonstrates the 
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capacity of the chloroplast to assemble tetrameric forms of the chimaeric 2L21-TD protein. The 
formation of oligomeric structures in the stroma of tobacco chloroplasts was previously shown 
for the cholera toxin B subunit (CTB) (Daniell et al. 2001) and the LTB protein (Kang et al. 
2003). 
Accumulation of foreign proteins levels above 1-2% of TSP can usually be directly visualized on 
Coomassie blue-stained polyacrilamide gels (Oey et al 2009a). To determine whether the 2L21-
TD accumulates to high levels in the stroma of our transplastomic plants, soluble protein 
extracts were separated by PAGE and stained with Coomassie brilliant blue. An 8 kDa band 
corresponding to the expected size of the 2L21-TD protein was observed in the samples of the 
transplastomic plant but was absent in the wild-type plant (Figure 2c). This result confirms the 
high levels of 2L21-TD protein accumulation in tobacco chloroplasts.  
The chloroplast protein biosynthesis is highly active in young leaves but successively declines 
with leaf age. This feature is frequently used as indicator of foreign protein stability. Relatively 
unstable proteins show a decline in protein accumulation with leaf age (Birch-Machin et al 2004; 
McCabe et al 2008). By contrast, stable proteins do not show this decline (Oey et al 2009a,b). 
To test the stability of the 2L21-TD protein, young, mature and old leaves (12, 8 and 3 leaf 
number, respectively, counted from the bottom of the plant) from 2L21-TD transplastomic plants 
grown for 60 days in a phytotron were used for TSP extraction. The TSP content of young, 
mature and old leaves were 12.9, 4.1 and 1.2 mg/g of fresh weight, respectively. When equal 
amounts of TSP were separated by SDS-PAGE and Coomassie blue-stained, no age-
dependent decline in 2L21-TD was detectable (Figure 2c). This result suggests that the 2L21-
TD protein is stable in the stroma of the chloroplast. 
For biotechnological applications it is important to quantify the yield of recombinant protein per 
plant and the relative contributions of young, mature and old leaves. Enzyme-linked 
immunosorbent assay (ELISA) was performed for quantification of the 2L21-TD protein. The 
ELISA protocol includes the mAb 3C9 as the primary antibody and has been described 
elsewhere (Molina et al. 2004). Young leaves showed the highest level of 2L21-TD, 0.4 mg/g 
fresh weight of leaf material, equivalent to ∼6% TSP (2% considering only the 2L21 peptide) 
(Figure 2d). The amount of 2L21-TD in mature leaves was slightly lower, and the levels in old 
senescent leaves were 2-fold lower than that in young leaves. According to the average number 
of leaves per plant and their fresh weight, approximately 30 mg of 2L21-TD can be extracted 
from a single plant. As expected, accumulation of the 2L21-TD protein in tobacco chloroplasts 
was much higher than in nuclear transformants of Arabidopsis (Gil et al. 2007). The pattern of 
lower levels of chimaeric proteins (relative to leaf fresh weight) in chloroplasts of old leaves has 
been previously described (Farran et al 2008; Molina et al. 2004; Scotti et al 2009). It has been 
shown that the decrease in recombinant protein accumulation according to the age of the leaf is 
parallel to the decrease in TSP content (Stevens et al 2000).  
These experiments demonstrate that the p53 TD could be expressed (as a fusion molecule to 
the 2L21 peptide) in tobacco chloroplasts and had the ability to form tetramers in the stroma. In 
addition, the use of the TD as a carrier molecule allowed the accumulation of the short 2L21 
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peptide in the chloroplast. As mentioned previously, the expression of short peptides as single 
molecules in recombinant systems, and specifically in transgenic plants, is difficult (Düring 
2001). For example, the antibacterial cecropin peptide was never detected in nuclear transgenic 
plants in one study (Florack et al. 1995), and transplastomic plants carrying the 2L21 sequence 
did not accumulate the corresponding peptide despite the presence of its specific mRNA 
(Molina et al. 2004). An exception is the expression of a 22-amino acid antimicrobial peptide in 
tobacco chloroplasts (DeGray et al. 2001). Although quantification was not performed, in vitro 
and in planta functional assays confirmed that this peptide was correctly expressed. The 2L21 
peptide is also 22 amino acids long, but it was not detected in tobacco chloroplasts. Differences 
in the amino acid sequence and in the estimated charge could explain the different stability of 
these peptides in the chloroplast. The antimicrobial peptide studied by DeGray et al. (2001) has 
an estimated charge of +6 at pH 7 (normal stromal pH in the dark), while the estimated charge 
of the 2L21 peptide is –1. 
The immunogenicity of chloroplast-derived 2L21-TD was analysed by intraperitoneal 
immunisation of female Balb/c mice and subsequent quantification of the induction of 2L21 and 
VP2-specific antibodies. Soluble protein extracts of leaves from transformed and non-
transformed plants were partially purified with 40-80% ammonium sulphate precipitation. 
Precipitated proteins were dialysed against PBS and antigens quantified by ELISA (Molina et al. 
2004). The parenteral immunisation protocol was performed as previously described (Molina et 
al. 2005). Briefly, antigen-enriched leaf extracts (29% purity; 20 µg 2L21-TD/dose and 70 µg 
total protein/dose) were administered with complete (first dose) or incomplete (second and third 
doses) Freund’s adjuvant. Blood was collected from the retro-orbital plexus at days 0 and 50. All 
serum samples were evaluated for the presence of 2L21 and VP2-specific antibodies by ELISA 
and dot blot. Titration of sera against the 2L21 epitope was carried out by an in-house ELISA 
test as described previously (Molina et al. 2004). As a positive control, a group of mice was 
immunised with a plant-derived CTB protein fused to the 2L21 peptide (CTB-2L21; 20 µg/dose) 
(Molina et al. 2004). All mice immunised with protein extracts from 2L21-TD or CTB-2L21 
transplastomic plants showed high antibody titres against the 2L21 peptide (Figure 3a). No 
specific antibodies (titre <10) were detected in the group immunised with protein extracts from 
the wild-type plant. In addition, sera from 2L21-TD- and CTB-2L21-immunised mice were able 
to recognise the recombinant VP2 protein produced in insect cells infected with baculovirus 
(Lopez de Turiso et al. 1992) (Figure 3b). This showed that the antigenicity of the 2L21 epitope 
was preserved in the 2L21-TD chimaeric product. Pre-immune sera and sera from control 
animals immunised with protein extracts from wild-type plants did not show positive reactions in 
the dot blot (Figure 3b).  
These immunisation experiments demonstrated that the 2L21-TD tetramers were at least as 
immunogenic as the CTB-2L21 pentamers. There are three reasons that favour the use of the 
p53 TD as an epitope carrier. First, the tertiary structure of the tetramer, as analysed by 
crystallography (Jeffrey et al. 1995) and nuclear magnetic resonance spectroscopy (Clore et al. 
1994), showed that the four N termini are equidistant and projected to the outer core of the 
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tetramer. This would facilitate proper arrangement of the epitope and favour its presentation to 
the immune system. Second, the TD is highly stable. It has been reported that TD-derived 
miniantibodies can remain stable for at least 72 h after inoculation in mice (Willuda et al. 2001). 
Third, despite the higher accumulation of CTB-2L21 (7.49 mg/g FW) (Molina et al. 2004) as 
compared to 2L21-TD (0.4 mg/g FW) in tobacco chloroplasts, CTB is a highly immunogenic 
protein. The recurrent use of CTB as a carrier molecule can induce tolerance and selectively 
suppress the anti-hapten antibody response (George Chandy et al. 2006; Renjifo et al. 1998; 
Schutze et al. 1989). As a consequence, CTB would not make a good general carrier protein for 
different antigens. On the other hand, the TD is a small domain (42 amino acids) derived from 
the p53 tumour suppressor protein that is highly conserved throughout vertebrate evolution 
(Walker et al. 1999). Therefore, it is expected to present low antigenicity in humans. These 
characteristics make the p53 TD a good candidate to be used as a general epitope carrier for 
applications in multiple vaccination protocols. 
In conclusion, the results presented in this paper demonstrate that the 64 amino acid sequence 
(2L21-TD) comprising the 2L21 peptide fused to the p53 tetramerisation domain can be 
efficiently expressed in tobacco chloroplasts, and that this chimaeric fusion is able to form 
tetramers that favour protein accumulation. This approach offers an easy and convenient way to 
express short peptides within the chloroplast. 
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